An in-depth look to NEXTBIOMEDICAL CO., LTD. operating, investing, and financing activities

389650 free cash flow for Q1 24 is -630.6 M KRW. For 2023, 389650 free cash flow was -4.22 B KRW and operating cash flow was -4.16 B KRW.